REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Eko-Drog Sp. z o.o. (Poland)

Main Activities: Engineering Services
Secondary Activities: Construction of Buildings | Heavy and Civil Engineering Construction | Specialty Trade Contractors | Other Activities Related to Credit Intermediation | Scientific Research and Development Services | Research and Development in the Physical, Engineering, and Life Sciences | All Other Professional, Scientific, and Technical Services | Services to Buildings and Dwellings | Landscaping Services
Full name: Eko-Drog Sp. z o.o. Profile Updated: April 26, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Polish Download a sample report

Eko-Drog Sp. z o.o. is a company based in Poland, with its head office in Rzeszow. The company operates in the Engineering Services sector. The enterprise was incorporated on September 14, 2016. Eko-Drog Sp. z o.o. currently employs 1 (2016) people. From the latest financial highlights, Eko-Drog Sp. z o.o. reported a net sales revenue increase of 36.28% in 2024. Its total assets grew by 54.89% over the same period. Eko-Drog Sp. z o.o.’s net profit margin decreased by 5.48% in 2024.

Headquarters
Ul. Maksymiliana Marii Kolbego 7/9
Rzeszow; Podkarpackie; Postal Code: 35-512

Contact Details: Purchase the Eko-Drog Sp. z o.o. report to view the information.

Basic Information
Total Employees:
Purchase the Eko-Drog Sp. z o.o. report to view the information.
Registered Capital:
Purchase the Eko-Drog Sp. z o.o. report to view the information.
Financial Auditors:
Purchase the Eko-Drog Sp. z o.o. report to view the information.
Incorporation Date:
September 14, 2016
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
Management Board Member
Ownership Details
Purchase this report to view the information.
50%
Purchase this report to view the information.
50%
Company Performance
Financial values in the chart are available after Eko-Drog Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
36.28%▲
Total operating revenue
45.53%▲
Operating profit (EBIT)
21.68%▲
EBITDA
22.47%▲
Net Profit (Loss) for the Period
15.05%▲
Total Assets
54.89%▲
Total Equity
56.77%▲
Operating Profit Margin (ROS)
-4.19%▼
Net Profit Margin
-5.48%▼
Return on Equity (ROE)
-13.13%▼

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo